Estrella Immunopharma, Inc.: Form 10-K/A for the period ended Jun 30, 2024
Filed with the SEC on Oct 28, 2024 and accepted by EDGAR at Oct 28, 2024, 17:03 ET.
Sections
No standard item headings were found in this filing’s main document, so no sections were extracted. Read the original on sec.gov. The main document on sec.gov.
Source: SEC EDGAR, the filing index for accession 0001213900-24-091250. Last ingested by Listed: Nov 4, 2026, 07:37 ET. Listed shows no prices and gives no investment advice.